Press releases 2
Browse GSK global press releases issued since 2009. Search them by keyword or browse by year/business category.
Press releases issued by our local operating companies can be viewed on our market websites.
-
Phase II study results showed comparable viral suppression rates at 96 weeks for a two-drug regimen of long-acting cabotegravir and rilpivirine and a three-drug regimen in patients with HIV.
Overview tab > Short description
Download1 (PDF, 35.3KB) -
Dominique Limet to step down as CEO of ViiV Healthcare; Deborah Waterhouse to succeed him
After seven years as CEO of ViiV Healthcare, Dr Dominique Limet will step down at the end of March 2017
-
News Article
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Suspendisse id erat finibus, porta ex vitae, vehicula neque. Phasellus nulla massa
